ARDX Ardelyx Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ARDX

Price (delayed)

$3.91

Market cap

$974.32M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.23

Enterprise value

$1.13B

?
Relative Growth: Rel. Growth: 66
Relative Strength: Rel. Strength: 7
Relative Valuation: Rel. Valuation: 20
Relative Profitability: Rel. Profitability: 38

Ardelyx was founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, ...

Highlights
The company's gross profit rose by 30% YoY and by 8% QoQ
The company's revenue rose by 17% YoY and by 5% QoQ
Ardelyx's debt has increased by 24% YoY and by 23% QoQ
The company's quick ratio fell by 21% YoY
Sector: Healthcare
Industry: Biotechnology
Website: http://www.ardelyx.com
Peers: OPK AMGN ABT AZN

Key stats

What are the main financial stats of ARDX

ARDX stock price

How has the Ardelyx stock price performed over time
Intraday
-1.51%
1 week
-19.71%
1 month
-23.93%
1 year
-32%
YTD
-32.93%
QTD
-23.33%

Financial performance

How have Ardelyx's revenue and profit performed over time
Revenue
$450.89M
Gross profit
$425.49M
Operating income
-$35.45M
Net income
-$55.7M
Gross margin
94.4%
Net margin
-12.4%
The company's gross profit rose by 30% YoY and by 8% QoQ
ARDX's operating margin is up by 25% year-on-year and by 9% since the previous quarter
The company's revenue rose by 17% YoY and by 5% QoQ
Ardelyx's net margin has increased by 15% YoY and by 9% QoQ

Price vs fundamentals

How does ARDX's price correlate with its fundamentals

Growth

What is Ardelyx's growth rate over time

Valuation

What is Ardelyx stock price valuation
P/E
N/A
P/B
6.48
P/S
2.15
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
2.51
The EPS has increased by 4.2% since the previous quarter
ARDX's P/B is 27% below its last 4 quarters average of 8.9
Ardelyx's equity has increased by 7% YoY
The price to sales (P/S) is 78% lower than the 5-year quarterly average of 9.8 and 35% lower than the last 4 quarters average of 3.3
The company's revenue rose by 17% YoY and by 5% QoQ

Efficiency

How efficient is Ardelyx business performance
The company's return on invested capital rose by 36% YoY and by 12% QoQ
The return on sales has increased by 27% year-on-year and by 13% since the previous quarter
Ardelyx's ROA has increased by 19% YoY and by 9% from the previous quarter
Ardelyx's ROE has increased by 6% from the previous quarter

Dividends

What is ARDX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ARDX.

Financial health

How did Ardelyx financials performed over time
ARDX's total assets is 35% greater than its total liabilities
ARDX's total liabilities is up by 30% year-on-year and by 20% since the previous quarter
ARDX's total assets is up by 23% year-on-year and by 14% since the previous quarter
Ardelyx's debt is 72% higher than its equity
Ardelyx's debt has increased by 24% YoY and by 23% QoQ
Ardelyx's debt to equity has increased by 23% QoQ and by 16% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.